SCHEMBL21247469

SCHEMBL21247469

O=C(O)c1ccnc2cccc(I)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
KDM4A O75164 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
HIF1AN Q9NWT6 1/20 0.42
KDM5A P29375 8/20 0.41
KDM5B Q9UGL1 6/20 0.41
KDM4C Q9H3R0 5/20 0.41
PSMD14 O00487 1/20 0.41
ASPH Q12797 1/20 0.40
KDM8 Q8N371 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CLK1 P49759 1/20 0.38
CLK2 P49760 1/20 0.38
GSK3B P49841 1/20 0.38
DYRK1A Q13627 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10464802 0.85 KDM4E (0.48) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL15129590 0.79 KDM4E (0.42) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL21257069 0.79 KDM5B (0.50) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL25261318 0.79 MMP2 (0.46) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL11669054 0.79 TSHR (0.47) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL7031514 0.78 KDM4E (0.44) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL18848334 0.77 ALDH1A1 (0.36) KDM4ETDP1LMNAALDH1A1MAPT
SCHEMBL28012267 0.76 LMNA (0.49) KDM4EKDM4AKDM5AKDM5BKDM4C
SCHEMBL28012268 0.76 DHODH (0.44) KDM4EKDM4AL3MBTL1RAB9AEGLN1
SCHEMBL30517039 0.74 KDM4E (0.50) KDM4EL3MBTL1ASPHKDM8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250127937-A1 FAP INHIBITOR UNIV HEIDELBERG (DE) 2025-04-24 US disclosed
CN-118146196-A FAP inhibitors 海德堡大学 2024-06-07 CN disclosed
US-20230112012-A1 FAP INHIBITOR UNIVERSITAT HEIDELBERG (DE) 2023-04-13 US disclosed
US-20230112012-A1 FAP INHIBITOR UNIVERSITAT HEIDELBERG (DE) 2023-04-13 US disclosed
US-20210038749-A1 FAP INHIBITOR Universität Heidelberg (DE) 2021-02-11 US disclosed
US-20210038749-A1 FAP INHIBITOR Universität Heidelberg (DE) 2021-02-11 US disclosed
EP-3749663-A1 FAP INHIBITOR Universität Heidelberg (DE) 2020-12-16 EP disclosed
CN-111699181-A FAP inhibitors 海德堡大学 2020-09-22 CN disclosed
WO-2019154859-A1 FAP INHIBITOR Universität Heidelberg (DE) 2019-08-15 WO disclosed
WO-2019154859-A1 FAP INHIBITOR Universität Heidelberg (DE) 2019-08-15 WO disclosed
WO-2019154886-A1 FAP INHIBITOR Universität Heidelberg (DE) 2019-08-15 WO disclosed
WO-2019154886-A1 FAP INHIBITOR Universität Heidelberg (DE) 2019-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210038749-A1 FAP INHIBITOR FAP, APC, FIBP KDM4E 2204/4885KDM4A 2408/4885L3MBTL1 4669/4885
US-20250127937-A1 FAP INHIBITOR FAP, APC, FIBP KDM4E 2204/4885KDM4A 2408/4885L3MBTL1 4669/4885
US-20230112012-A1 FAP INHIBITOR FAP, APC, FIBP KDM4E 2204/4885KDM4A 2408/4885L3MBTL1 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.